Sun-Kissed Serenity: Morning Rays for a Brighter Mind

December 19, 2025 updated by: Efforia, Inc
Sun-Kissed Serenity: Morning Rays for a Brighter Mind is a 30-day dawn rendezvous with nature. Participants are asked to stand outside for 15 minutes each morning, track progress with surveys, and support mental health with natural light.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

This remotely administered decentralized trial is designed to meticulously evaluate the impact of daily morning sunlight exposure on mental well-being over a span of 30 days. In an era where society is increasingly fraught with overstimulation and stress, this study seeks to explore a simple, natural intervention that has been both scientifically and anecdotally linked to improved mental health outcomes. Leveraging the NIH Toolbox® Positive Affect Survey and the Personal Feelings Survey, this online study aims to quantify the effects of a 15-minute morning sunlight exposure routine on participants' mood, stress levels, and overall sense of well-being.

The objective behind this innovative approach is to empower individuals to discover the potential mental health benefits of integrating a brief period of sunlight exposure into their daily morning routine. By participating in this trial, individuals are not only taking an active step towards potentially enhancing their own mental wellness but are also contributing valuable data to a broader scientific endeavor aimed at validating a cost-free, accessible method for supporting mental health.

This study will utilize a variety of validated tools to rigorously assess changes in participants' emotional states and personal well-being throughout the trial period. This includes tracking shifts in positive affect, stress levels, and overall mood, to determine whether this straightforward daily practice can yield significant improvements in mental health metrics.

The significance of this study lies in its potential to offer a low-cost, universally accessible intervention for enhancing mental wellness without the need for pharmaceuticals, subscriptions, or the risk of adverse side effects. Despite variables such as weather conditions or individual daily routines, the prospect of establishing a free, evidence-based practice for reducing stress and elevating mood holds considerable promise. Through this remotely conducted trial, the investigators aim to gather conclusive evidence on the efficacy of morning sunlight exposure as a tool for mental health support, thereby contributing to the development of simple, natural strategies for managing stress and improving emotional well-being in today's fast-paced world.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • New York, New York, United States, 10003
        • Efforia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single arm where participants act as their own control
Behavioral: Morning sunlight
Participants are asked to get 15 minutes of morning sunlight every day for 30 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NIH Toolbox® Item Bank v3.0 - Positive Affect Survey (Ages 18+) Score
Time Frame: Change from baseline (Day 1-3) in positive affect scores at 4 weeks after the start of the intervention (Day 28-32)
This survey assesses your level of positive affect in the past 7 days. Please respond to each question or statement by selecting one option that best describes your feelings or experiences.
Change from baseline (Day 1-3) in positive affect scores at 4 weeks after the start of the intervention (Day 28-32)
Personal Feelings Survey
Time Frame: Change from baseline (Day 1-3) in feelings of isolation scores at 4 weeks after the start of the intervention (Day 28-32)
This survey aims to understand your personal feelings, particularly about being alone or feeling isolated. You are asked to indicate how often you feel a certain way.
Change from baseline (Day 1-3) in feelings of isolation scores at 4 weeks after the start of the intervention (Day 28-32)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Efforia, Inc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 11, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

November 20, 2025

First Submitted That Met QC Criteria

November 20, 2025

First Posted (Estimated)

December 1, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 37231

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Status Change

Clinical Trials on Morning sunlight

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe